Biomolecular coronas provide the biological identity of nanosized materials

Nature Nanotechnology

Volumn 7, Issue 12, 2012, Pages 779-786

  Monopoli, Marco P ^a   Åberg, Christoffer ^a   Salvati, Anna ^a   Dawson, Kenneth A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; MOLECULAR BIOLOGY; NANOPARTICLES;

BASIC CONCEPTS; BIO-MOLECULAR; BIOLOGICAL FLUIDS; BIOLOGICAL IMPACTS; CRITICAL ASSESSMENT; LIVING ORGANISMS; NANOSIZED MATERIALS; POTENTIAL THREATS;

DRUG DELIVERY;

BIOMOLECULAR CORONA; CARBON NANOTUBE; NANOPARTICLE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSPORT; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; INTRACELLULAR SIGNALING; NANOBIOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 84873853768     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2012.207     Document Type: Article

References (110)

1. Cedervall, T. et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA 104, 2050-2055 (2007).
2. Nel, A. E. et al. Understanding biophysicochemical interactions at the nano-bio interface. Nature Mater. 8, 543-557 (2009).
3. Lynch, I. & Dawson, K. A. Protein-nanoparticle interactions. Nano Today 3, 40-47 (2008).
4. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A. & McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428-437 (2009).
5. Tenzer, S. et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5, 7155-7167 (2011).
6. Ge, C. et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl Acad. Sci. USA 108, 16968-16973 (2011).
7. Ang, J. C., Lin, J-M., Yaron, P. N. & White, J. W. Protein trapping of silica nanoparticles. Soft Matter 6, 383-390 (2010).
8. Walczyk, D., Baldelli Bombelli, F., Monopoli, M. P., Lynch, I. & Dawson, K. A. What the cell "sees" in bionanoscience. J. Am. Chem. Soc. 132, 5761-5768 (2010).
9. Röcker, C., Pötzl, M., Zhang, F., Parak, W. J. & Nienhaus, G. U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature Nanotech. 4, 577-580 (2009).
10. Deng, Z. J., Liang, M., Monteiro, M., Toth, I. & Minchin, R. F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotech. 6, 39-44 (2011).
11. Walkey, C. D. & Chan, W. C. W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41, 2780-2799 (2012).
12. Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J. & Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano 4, 3623-3632 (2010).
13. Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA 105, 14265-14270 (2008).
14. Monopoli, M. P. et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133, 2525-2534 (2011).
15. Deng, Z. J. et al. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20, 455101 (2009).
16. Milani, S., Baldelli Bombelli, F., Pitek, A. S., Dawson, K. A. & Rädler, J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 6, 2532-2541 (2012).
17. Anderson, N. L. & Anderson, N. G. The human plasma proteome. Mol. Cell. Proteomics 1, 845-867 (2002).
18. Zhang, H. et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics 11, 4569-4577 (2011).
19. Dobrovolskaia, M. A. et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed. Nanotech. Biol. Med. 5, 106-117 (2009).
20. Martel, J. et al. Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. Anal. Biochem. 418, 111-125 (2011).
21. Dufort, S., Sancey, L. & Coll, J-L. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv. Drug Deliv. Rev. 64, 179-189 (2012).
22. Maiorano, G. et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4, 7481-7491 (2010).
23. Simberg, D. et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 30, 3926-3933 (2009).
24. Mahmoudi, M. et al. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 111, 5610-5637 (2011).
25. Gasser, M. et al. The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J. Nanobiotechnol. 8, 31 (2010).
26. Lundqvist, M. et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5, 7503-7509 (2011).
27. Schleh, C. et al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 6, 36-46 (2012).
28. Choi, H. S. et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nature Biotechnol. 28, 1300-1303 (2010).
29. Oberdörster, G., Elder, A. & Rinderknecht, A. Nanoparticles and the brain: cause for concern? J. Nanosci. Nanotechnol. 9, 4996-5007 (2009).
30. Gaddum, J. Gaddum's Pharmacology 9th edn (Oxford Univ. Press,1985).
31. Ekdahl, K. N. et al. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv. Drug Deliv. Rev. 63, 1042-1050 (2011).
32. Gorbet, M. B. & Sefton, M. V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25, 5681-5703 (2004).
33. Rejman, J., Oberle, V., Zuhorn, I. S. & Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 377, 159-169 (2004).
34. Chithrani, B. D., Ghazani, A. A. & Chan, W. C. W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662-668 (2006).
35. Kim, H. R. et al. Analysis of plasma protein adsorption onto PEG ylated nanoparticles by complementary methods: 2-DE, CE and protein lab-on-chip system. Electrophoresis 28, 2252-2261 (2007).
36. Prapainop, K., Witter, D. P. & Wentworth, P. A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. J. Am. Chem. Soc. 134, 4100-4103 (2012).
37. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nature Rev. Cancer 5, 161-171 (2005).
38. Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A. & Irvine, D. J. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nature Med. 16, 1035-1041 (2010).
39. Otsuka, H., Nagasaki, Y. & Kataoka, K. PEG ylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55, 403-419 (2003).
40. Hamad, I. et al. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 4, 6629-6638 (2010).
41. Hoshino, Y. et al. Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J. Am. Chem. Soc. 132, 6644-6645 (2010).
42. Lesniak, A. et al. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6, 5845-5857 (2012).
43. Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803-833 (2010).
44. Hu, W. et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5, 3693-3700 (2011).
45. Verma, A. et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nature Mater. 7, 588-595 (2008).
46. Salvati, A. et al. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: towards models of uptake kinetics. Nanomed. Nanotechnol. Biol. Med. 7, 816-826 (2011).
47. Doherty, G. J. & McMahon, H. T. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857-902 (2009).
48. Dausend, J. et al. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol. Biosci. 8, 1135-1143 (2008).
49. Iversen, T. G., Skotland, T. & Sandvig, K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 6, 176-185 (2011).
50. Shapero, K. et al. Time and space resolved uptake study of silica nanoparticles by human cells. Mol. Biosyst. 7, 371-378 (2011).
51. Lesniak, A. et al. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31, 9511-9518 (2010).
52. Ehrenberg, M. S., Friedman, A. E., Finkelstein, J. N., Oberdörster, G. & McGrath, J. L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30, 603-610 (2009).
53. Zhu, Y. et al. Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles. Carbon 47, 1351-1358 (2009).
54. Bajaj, A., Samanta, B., Yan, H., Jerry, D. J. & Rotello, V. M. Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4 nanoparticles. J. Mater. Chem. 19, 6328-6331 (2009).
55. Lunov, O. et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5, 1657-1669 (2011).
56. Kapralov, A. A. et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6, 4147-4156 (2012).
57. Konduru, N. V. et al. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS ONE 4, e4398 (2009).
58. Georgieva, J. V. et al. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol. Ther. 19, 318-325 (2011).
59. Kreuter, J. et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 10, 317-325 (2002).
60. Schleh, C., Rothen-Rutishauser, B. & Kreyling, W. G. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur. J. Pharm. Biopharm. 77, 350-352 (2011).
61. Boraschi, D., Costantino, L. & Italiani, P. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine 7, 121-131 (2011).
62. Huo, Q. et al. A facile nanoparticle immunoassay for cancer biomarker discovery. J. Nanobiotechnol. 9, 20 (2011).
63. Ghosh, P. et al. Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J. Am. Chem. Soc. 132, 2642-2645 (2010).
64. Doorley, G. W. & Payne, C. K. Cellular binding of nanoparticles in the presence of serum proteins. Chem. Commun. 47, 466-468 (2011).
65. Sée, V. et al. Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano 3, 2461-2468 (2009).
66. Marano, F., Hussain, S., Rodrigues-Lima, F., Baeza-Squiban, A. & Boland, S. Nanoparticles: molecular targets and cell signalling. Arch. Toxicol. 85, 733-741 (2011).
67. Wang, J. et al. Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner. Nano Lett. 11, 4985-4991 (2011).
68. Gagner, J. E., Lopez, M. D., Dordick, J. S. & Siegel, R. W. Effect of gold nanoparticle morphology on adsorbed protein structure and function. Biomaterials 32, 7241-7252 (2011).
69. Roach, P., Farrar, D. & Perry, C. C. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J. Am. Chem. Soc. 128, 3939-3945 (2006).
70. Mandal, H. S. & Kraatz, H. B. Effect of the surface curvature on the secondary structure of peptides adsorbed on nanoparticles. J. Am. Chem. Soc. 129, 6356-6357 (2007).
71. Brown, D. M., Dickson, C., Duncan, P., Al-Attili, F. & Stone, V. Interaction between nanoparticles and cytokine proteins: impact on protein and particle functionality. Nanotechnology 21, 215104 (2010).
72. Lacerda, S. H. et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4, 365-379 (2010).
73. Linse, S. et al. Nucleation of protein fibrillation by nanoparticles. Proc. Natl Acad. Sci. USA 104, 8691-8696 (2007).
74. Hubbell, J. A., Thomas, S. N. & Swartz, M. A. Materials engineering for immunomodulation. Nature 462, 449-460 (2009).
75. Fadeel, B. & Garcia-Bennett, A. E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 62, 362-374 (2010).
76. Karmali, P. P. & Simberg, D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin. Drug Deliv. 8, 343-357 (2011).
77. Salvador-Morales, C. et al. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 43, 193-201 (2006).
78. Xia, X. R., Monteiro-Riviere, N. A. & Riviere, J. E. An index for characterization of nanomaterials in biological systems. Nature Nanotech. 5, 671-675 (2010).
79. Nanda, K. K., Maisels, A., Kruis, F. E., Fissan, H. & Stappert, S. Higher surface energy of free nanoparticles. Phys. Rev. Lett. 91, 106102 (2003).
80. Chakraborty, S. et al. Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir 27, 7722-7731 (2011).
81. Dutta, D. et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 100, 303-315 (2007).
82. Caracciolo, G. et al. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. Langmuir 27, 15048-15053 (2011).
83. Gessner, A., Paulke, B. R. & Müller, R. H. Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: comparison of sample application and isoelectric focusing techniques. Electrophoresis 21, 2438-2442 (2000).
84. Sund, J., Alenius, H., Vippola, M., Savolainen, K. & Puustinen, A. Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. ACS Nano 5, 4300-4309 (2011).
85. Hellstrand, E. et al. Complete high-density lipoproteins in nanoparticle corona. FEBS J. 276, 3372-3381 (2009).
86. Zeng, Z. et al. Synthetic polymer nanoparticle-polysaccharide interaction: a systematic study. J. Am. Chem. Soc. 134, 2681-2690 (2012).
87. Lartigue, L. et al. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano 6, 2665-2678 (2012).
88. Hunter, R. J. Foundations of Colloid Science 2nd edn (Oxford Univ. Press, 2001).
89. Tsai, D. H. et al. Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. Langmuir 27, 2464-2477 (2011).
90. Turci, F. et al. An integrated approach to the study of the interaction between proteins and nanoparticles. Langmuir 26, 8336-8346 (2010).
91. Sapsford, K. E., Tyner, K. M., Dair, B. J., Deschamps, J. R. & Medintz, I. L. Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques. Anal. Chem. 83, 4453-4488 (2011).
92. Li, L., Mu, Q., Zhang, B. & Yan, B. Analytical strategies for detecting nanoparticle-protein interactions. Analyst 135, 1519-1530 (2010).
93. Henzler, K. et al. Interaction strength between proteins and polyelectrolyte brushes: a small angle X-ray scattering study. Phys. Chem. Chem. Phys. 13, 17599-17605 (2011).
94. Brewer, S. H., Glomm, W. R., Johnson, M. C., Knag, M. K. & Franzen, S. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir 21, 9303-9307 (2005).
95. Liu, S. et al. Investigations on the interactions between plasma proteins and magnetic iron oxide nanoparticles with different surface modifications. J. Phys. Chem. C 114, 21270-21276 (2010).
96. De Puig, H., Federici, S., Baxamusa, S. H., Bergese, P. & Hamad-Schifferli, K. Quantifying the nanomachinery of the nanoparticle- biomolecule interface. Small 7, 2477-2484 (2011).
97. Giri, J. et al. Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms. ACS Nano 5, 3456-3468 (2011).
98. Wu, Z. C., Zhang, B. & Yan, B. Regulation of enzyme activity through interactions with nanoparticles. Int. J. Mol. Sci. 10, 4198-4209 (2009).
99. Obata, S. & Honda, K. Dynamic behavior of carbon nanotube and bio-/artificial surfactants complexes in an aqueous environment. J. Phys. Chem. C 115, 19659-19667 (2011).
100. Hung, A. et al. Ordering surfaces on the nanoscale: implications for protein adsorption. J. Am. Chem. Soc. 133, 1438-1450 (2011).
101. Dell'Orco, D., Lundqvist, M., Oslakovic, C., Cedervall, T. & Linse, S. Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS ONE 5, e10949 (2010).
102. Gao, J. et al. Dispersion and toxicity of selected manufactured nanomaterials in natural river water samples: effects of water chemical composition. Environ. Sci. Technol. 43, 3322-3328 (2009).
103. Keller, A. A. et al. Stability and aggregation of metal oxide nanoparticles in natural aqueous matrices. Environ. Sci. Technol. 44, 1962-1967 (2010).
104. Schulze, C., Schaefer, U. F., Ruge, C. A., Wohlleben, W. & Lehr, C. M. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur. J. Pharm. Biopharm. 77, 376-383 (2011).
105. Kreyling, W. G. et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 21, 55-60 (2009).
106. Faunce, T. A., White, J. & Matthaei, K. I. Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomedicine 3, 859-866 (2008).
107. Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona absorbs on the surface. Nature Nanotech. (in the press).
108. Sandin, P., Fitzpatrick, L. W., Simpson, J. C. & Dawson, K. A. High-speed imaging of Rab family small GT Pases reveals rare events in nanoparticle trafficking in living cells. ACS Nano 6, 1513-1521 (2012).
109. Lowry, G. V., Gregory, K. B., Apte, S. C. & Lead, J. R. Transformations of nanomaterials in the environment. Environ. Sci. Technol. 46, 6893-6899 (2012).
110. Quik, J. T. et al. Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere 81, 711-715 (2010).